Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by tylerreddickon Mar 13, 2024 3:50pm
93 Views
Post# 35931230

RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations

RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
biorun wrote: 1067 my good buddy is licensed globally and with an organization far more competent and resources than Sirona to bring to market.

Like I said, if one believes that Allergan will get to market, then 8 cents is a bargain, if you don't well then 8 cents is a fair assessment.

As for you, you keep promising to put me on ignore but you simply can't stick to your word. How about you start now?


You will note that I hadn't responded to your drivel for quite some time, as I did have you on ignore.
I took you off today just to see if anything has changed, and no, it hasn't. All you post is mindless word salad. And you don't support the share price with buying, even when it is "cheap" in your "expert" opinion. 

So yes, you can quite easily go back on ignore. Bye bye.
<< Previous
Bullboard Posts
Next >>